Text

Catalog of tumor microbiotas finds bacteria living inside many cancer cells

Researchers have created a catalog of the bacteria associated with all the cancer types. The findings could help to enhance the actions of anticancer drugs.

Bacterial viruses could modulate the gut microbiota to fight colorectal cancer

Researchers developed a new tool to modulate the gut microbiota for neutralizing the tumor-promoting microenvironment.

How the microbiota shapes the development of the immune system

A. Macpherson et al. reviewed studies that looked at the interaction between the gut microbiota and their mammalian hosts, from fetal development to the early postnatal period.

Cholesterol-lowering drugs could influence the gut microbiota in obese people

Obese people have a gut microbiota that is associated with inflammation. But those who take statins have a healthier gut microbiota, a new study (Nature) found.

Takeda and Debiopharm agree licencing deal for GI targeted novel microbiome therapeutics

A new study helps to explain how nerve cells sense the microbes in the gut and how they coordinate their function with other tissues in the digestive tract.

AGA release new guidelines for taking probiotics

The American Gastroenterological Association (AGA) evaluated available evidence on clinical efficacy of probiotics for most digestive conditions.

Drug halts C. difficile infection, promotes recovery of the microbiota after antibiotic treatment

Ebselen may protect from C. difficile-associated tissue damage and bolster recovery of the microbiota after antibiotic treatment.

Gut microbiota could inhibit the growth of antibiotic-resistant bacteria

A new study shows that interactions with the resident gut microbiota could suppress the proliferation and antibiotic-resistance evolution of superbugs.

How gut bacteria contribute to the development of colorectal cancer

A new study supports the idea that the gut microbiota composition can vary in abundance and function during the development of colorectal cancer.

The path towards microbiota-based therapies

In a commentary published in Cell, five experts discuss the challenges and opportunities of microbiota-based therapies.

Subscribe to MicrobiomePost newsletter

Take full advantage of MicrobiomePost‘s features.

Scroll to Top